Ticker
IMCCCompany Name
IM CANNABIS CORPSector
HealthcareIndustry
Drug Manufacturers - Specialty & GenericExchange
NASDAQDate | Earnings Before Interest Taxes & Depreciation Amortization (EBITDA) | EBITDA Margin | Revenues |
---|---|---|---|
6/30/2025 | $ 5.04M | 13.17% | $ 38.26M |
3/31/2025 | $ 769.29K | 1.98% | $ 38.91M |
12/31/2024 | $ -3.44M | -9.18% | $ 37.52M |
9/30/2024 | $ -4.73M | -12.79% | $ 36.97M |
6/30/2024 | $ -5.22M | -14.54% | $ 35.89M |
3/31/2024 | $ -3.21M | -9.11% | $ 35.28M |
12/31/2023 | $ -1.51M | -4.22% | $ 35.89M |
9/30/2023 | $ -21.82M | -56.59% | $ 38.56M |
6/30/2023 | $ -117.09M | -280.95% | $ 41.67M |
3/31/2023 | $ -122.74M | -254.36% | $ 48.25M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
EBITDA / Revenues
(=) EBITDA %
EBITDA % for IM CANNABIS CORP is calculated as follows: EBITDA [ $ -5.56M ] / Revenues [ $ 12.61M ]
(=) EBITDA % [ -44.07% ]
Minimum
Dec 31, 2022
Maximum
Jun 30, 2025
Average
Median
filtered constituents | 3.29K |
---|---|
min | -75.07% |
max | 97.73% |
average | 16.12% |
median | 14.72% |
std | 26.88% |